Linda focuses on legal frameworks governing ownership, access, use and regulation of biotechnologies in the United States and internationally. She counsels clients on a variety of biotechnology-related issues, including patenting, open source technologies, multilateral treaties and compliance.

Linda has served on the Committee on Intellectual Property and Ownership Issues in Synthetic Biology for the U.S. National Research Council, and has been appointed as a Visiting Scholar at Stanford University, a Policy Fellow at the University of Cambridge Centre for Science and Policy, and as a Visiting Scholar at the University of Cambridge Faculty of Law. She has contributed to findings of the Convention on Biological Diversity on the emergence and growth of digital sequence information, and to development by the World Health Organization of an MTA guidance tool in preparedness for public health emergencies.

Linda writes and lectures on topics relating to biotechnology law and policy. She has been an invited speaker at numerous venues, including conferences of the World Health Organization, European Science Open Forum, Global Bio Summit, and the U.S. National Academy of Sciences’ Committee on Science, Technology and Law.

Prior to practicing law, Linda was trained as a research scientist. She received her Bachelor of Science in Biology from the University of California, Los Angeles (UCLA), her Master of Science and PhD in cell biology and biochemistry from Princeton University, and completed postdoctoral studies in genetics at the University of California, Berkeley. Linda received her Juris Doctorate, magna cum laude, from Santa Clara University School of Law, earning the High Tech Law Certificate with an emphasis in intellectual property law.  She is admitted to practice in California and before the United States Patent and Trademark Office (USPTO).